Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:56:47.096Z.
Calculation as of: 2026-10-06T14:56:47.096Z.
Quote observation: 2026-10-06T14:55:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b1e589d4888711efc6e495fe73fbc3b606428562d81b06b8c422d1cee3adbcc2
EARNINGS YIELD
N/A
Establishment Labs Holdings Inc.
Market Cap
$1.96B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.00B
Earnings Yield
6.69%
TTM Avg
6.22%
3Y Avg
3.42%
5Y Avg
3.42%
Market Cap
$2.01B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01B
Earnings Yield
14.63%
TTM Avg
9.78%
3Y Avg
7.02%
5Y Avg
7.02%
Market Cap
$2.02B
Earnings Yield
N/A
TTM Avg
13.14%
3Y Avg
13.14%
5Y Avg
13.14%
Market Cap
$1.89B
Earnings Yield
2.65%
TTM Avg
2.81%
3Y Avg
2.81%
5Y Avg
0.91%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.96B | N/A | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $1.97B | N/A | 98.76% | 98.76% | 79.11% |
| Immunome, Inc. (IMNM)vs › | $1.94B | N/A | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.00B | 6.69% | 6.22% | 3.42% | 3.42% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.01B | N/A | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.01B | 14.63% | 9.78% | 7.02% | 7.02% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | N/A | 13.14% | 13.14% | 13.14% |
| Azenta, Inc. (AZTA)vs › | $1.89B | N/A | 1.68% | 5.59% | 5.05% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 2.65% | 2.81% | 2.81% | 0.91% |
| Alvotech (ALVO)vs › | $2.04B | N/A | 3.77% | 3.77% | 3.77% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
